• English
  • Sign In
  • Contact Us
Catalog Products » Antibodies » Primary Antibodies » Immune Checkpoint Antibodies » Anti-Obinutuzumab Antibody, pAb, Rabbit

Anti-Obinutuzumab Antibody, pAb, Rabbit

Synonyms Rabbit polyclonal to Gazyva
Description Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients, and as a second line treatment for follicular lymphoma. Obinutuzumab is a fully humanized monoclonal antibody that binds to an epitope on CD20 that partially overlaps with the epitope recognized by rituximab. Obinutuzumab binds to CD20 on B cells and causes these cells to be destroyed by engaging the adaptive immune system, directly activating intracellular apoptosis pathways, and activating the complement system.
Host Species Rabbit
Conjugation Unconjugated
Immunogen Obinutuzumab
Purification Antigen affinity column

Concentration 0.5 mg/ml, lyophilized with PBS, pH 7.4, contains 0.02% sodium azide. (Might be eligible for customized bulk orders.)
Reconstitution Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
Specificity The product is specific for Obinutuzumab. This antibody serves as an excellent positive control for Obinutuzumab immunogenicity (ADA) assays.
Storage The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid freeze/thaw cycles.
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Working concentrations for specific applications should be determined by the investigators. The appropriate concentration may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.

ELISA detection: 0.005-1 µg/ml
Other applications: user-optimize

  • Anti-Obinutuzumab Antibody, PAb, Rabbit
  • Anti-Obinutuzumab Antibody, PAb, Rabbit

    ELISA binding of Anti-Obinutuzumab Antibody, pAb, Rabbit (GenScript, A01933-40) with Obinutuzumab.
    Coating antigen: Obinutuzumab, 1 µg/ml.
    Anti-Obinutuzumab Antibody, pAb, Rabbit (GenScript, A01933-40) dilution start from 1,000 ng/ml, EC₅₀= 4.845 ng/ml.

Cat. No.
Product Name
Anti-Obinutuzumab Antibody (16B7) [Biotin], mAb, Mouse - 40 µg
Anti-Obinutuzumab Antibody (16B7), mAb, Mouse - 40 µg
Anti-Obinutuzumab Antibody (18H8), mAb, Mouse - 40 µg

Notice there is no results found, you can visit "Citations Database" for other results.

For more documents, please visit "Technical Support".

Cat. No. A01933
40 µg $198.00